GASTROINTESTINAL STROMAL TUMOR
Clinical trials for GASTROINTESTINAL STROMAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMOR trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare GIST: targeted pill shows promise in early trial
Disease control Recruiting nowThis phase 2 study tests the drug pemigatinib in 24 people with advanced SDH-deficient GIST, a rare stomach cancer that has spread. The drug is a pill that blocks certain growth signals in cancer cells. Researchers will measure how many patients' tumors shrink and track side effe…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
New study aims to close gaps in cancer care for black patients
Knowledge-focused Recruiting nowThis study is for Black adults newly diagnosed with gastrointestinal cancer. It focuses on ensuring patients receive proper biomarker testing and evidence-based care, helping them find and join clinical trials if they choose, and providing easy-to-understand information about the…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:08 UTC